VALIDATION IMAGES
Lane 1: SH-SY5Y Cells; Lane 2: HepG2 Cells; Lane 3: Mouse Stomach; Lane 4: Human Stomach; Probed with TP53INP1 (6C1) Monoclonal Antibody (bsm-54370R) at 1:500, overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
IF(ICC) staining with TP53INP1 (6C1) Monoclonal Antibody (bsm-54370R) at 1:100 in HepG2 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with TP53INP1 (6C1) Monoclonal Antibody (bsm-54370R) at 1:100 in HUVEC cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
Paraformaldehyde-fixed and paraffin-embedded Human Liver Cancer tissue incubated with TP53INP1 (6C1) Monoclonal Antibody (bsm-54370R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human Kidney tissue incubated with TP53INP1 (6C1) Monoclonal Antibody (bsm-54370R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human Pancreas tissue incubated with TP53INP1 (6C1) Monoclonal Antibody (bsm-54370R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
IF(ICC) staining with TP53INP1 (6C1) Monoclonal Antibody (bsm-54370R) at 1:100 in HUVEC cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.